Treasurer Of The State Of North Carolina Novavax Inc Transaction History

Treasurer Of The State Of North Carolina

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$5.76 - $12.48 $21,081 - $45,676	3,660 Added 10.81%	37,530 $260,000
Q4 2022 Feb 09, 2023	BUY	$8.86 - $25.04 $3,809 - $10,767	430 Added 1.29%	33,870 $348,000
Q3 2022 Nov 08, 2022	BUY	$18.2 - $76.12 $7,826 - $32,731	430 Added 1.3%	33,440 $609,000
Q2 2022 Aug 02, 2022	BUY	$36.28 - $75.29 $190,034 - $394,369	5,238 Added 18.86%	33,010 $1.7 Million
Q1 2022 May 10, 2022	SELL	$69.73 - $142.9 $1.41 Million - $2.9 Million	-20,278 Reduced 42.2%	27,772 $2.05 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $51,132 - $82,828	-380 Reduced 0.78%	48,050 $6.88 Million
Q3 2021 Nov 03, 2021	BUY	$177.8 - $270.58 $163,398 - $248,663	919 Added 1.93%	48,430 $10 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $3.42 Million - $7.29 Million	28,280 Added 147.05%	47,511 $10.1 Million
Q1 2021 May 03, 2021	BUY	$112.98 - $319.93 $2.17 Million - $6.15 Million	19,231 New	19,231 $3.49 Million

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.